Professor Eneida Mioshi
Professor Eneida Mioshi trained as an occupational therapist at the University of Sao Paulo (USP), Brazil. While working as an independent occupational therapist in Sao Paulo, she undertook a MSc in Sciences at USP. Upon completion of her MSc, she relocated to Cambridge, UK, in 2003. Eneida then started full-time clinical research work at the Department of Clinical Neurosciences at Cambridge University, followed by a concomitant PhD in Applied Cognitive Psychology at the MRC Cognition and Brain Sciences Unit (CBU). Her PhD investigated the practical impact of Frontotemporal Dementia (FTD) on everyday life, particularly in relation to loss of independence, FTD progression and how to better stage it, and the impact of the FTD on family carers’ well-being. Her PhD supervisor was Professor John Hodges.
Eneida relocated to Neuroscience Research Australia in Sydney in 2007, to start a postdoctoral role with Prof Hodges, testing ways to better support family members affected by FTD. A few years later, she was awarded an Australian NHMRC Postdoctoral Fellowship, taking her research experience from FTD into Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS). She has developed a programme of research investigating non-motor symptoms in MND/ALS, particularly focused on cognitive and behavioural symptoms which overlap with FTD. Eneida was awarded several project grants in this field (MNDRIA), working closely with Professor Matthew Kiernan.
In 2013, Eneida returned to the UK to work at the Department of Psychiatry at Cambridge University. She subsequently was awarded an Alzheimer’s Society Senior Fellowship and was appointed Chair of Dementia Care Research at the School of Health Sciences, University of East Anglia, in 2015.
Regionally, she had various leadership roles in the East of England. She was Deputy Director of the NIHR Applied Research Collaboration – ARC (then CLAHRC) in 2016 (2016-2022), and the NIHR ARC Academic Career Development Lead (2017-2025). Eneida was involved in various programmes from the NIHR Academy, and other early career initiatives such as the Wellcome PhD programme established between the Universities of Cambridge and University of East Anglia, enabling capacity building for research.
Eneida continues to develop her research programme in neurodegeneration, with two key areas of focus: 1) development of outcome measures for clinical and research use, and 2) standardised support for family members involved in the care of someone with FTD, MND (also known as ALS), or both, funded by grants from the MND Association, MND Scotland, and other UK funding bodies.
You can access her scientific track record here:
Eneida Mioshi — University of East Anglia (uea.ac.uk)